Exploring the Physiological Mechanisms of Austism Through Organoids

Brief summary (registry, in English)

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder affecting approximately 1% of the population, characterized by difficulties with social interaction and communication. Studies have identified more than 200 genes linked to ASD, particularly those involved in chromatin remodeling and synaptic neuronal connectivity (CHD8, SCN2A, NLGN3-4X, SHANK1-3). The goal of the project is to decipher the biological mechanisms underlying ASD in order to develop therapeutic strategies, using innovative preclinical models such as organoids.

What you commit to

• Study type: Observational
• Planned participants: 80
• From 1 May 2026 to the primary completion date, 1 May 2028
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.